Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | ACE | P12821 | 8/20 | 0.41 |
| ▸ | REN | P00797 | 3/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | F2 | P00734 | 1/20 | 0.41 |
| ▸ | LTA4H | P09960 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | PEPD | P12955 | 1/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.41 |
| ▸ | HTR2A | P28223 | 1/20 | 0.41 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.41 |
| ▸ | HRH1 | P35367 | 1/20 | 0.41 |
| ▸ | THPO | P40225 | 1/20 | 0.41 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26691320 | 1.00 | ALDH1A1 (0.44) | ALDH1A1SMN1; SMN2RAB9AACEREN | |
| SCHEMBL202763 | 1.00 | ALDH1A1 (0.44) | ALDH1A1SMN1; SMN2RAB9AACEREN | |
| Hydrochloric Acid SCHEMBL3924876 | 0.98 | ALDH1A1 (0.42) | ALDH1A1SMN1; SMN2RAB9AACEREN | |
| SCHEMBL443175 | 0.83 | ALDH1A1 (0.40) | ALDH1A1SMN1; SMN2RAB9AACEREN | |
| SCHEMBL443176 | 0.83 | ALDH1A1 (0.40) | ALDH1A1SMN1; SMN2RAB9AACEREN | |
| SCHEMBL30675399 | 0.82 | POLB (0.47) | ALDH1A1SMN1; SMN2LTA4HPEPDPOLB | |
| SCHEMBL13017410 | 0.82 | DPP4 (0.38) | ALDH1A1SMN1; SMN2MAPTPOLB | |
| SCHEMBL3349893 | 0.81 | ALDH1A1 (0.41) | ALDH1A1SMN1; SMN2RAB9AACEREN | |
| SCHEMBL3349891 | 0.81 | ALDH1A1 (0.41) | ALDH1A1SMN1; SMN2RAB9AACEREN | |
| SCHEMBL27682627 | 0.80 | RAB9A (0.41) | ALDH1A1SMN1; SMN2RAB9AACEREN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12084462-B2 | Spiro bicyclic inhibitors of menin-MLL interaction | JANSSEN PHARMACEUTICA NV (BE) | 2024-09-10 | — | — | US | disclosed |
| WO-2024061370-A1 | PYRIMIDINE-FUSED RING COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF | 劲方医药科技(上海)有限公司 | 2024-03-28 | — | — | WO | disclosed |
| WO-2023030385-A1 | PYRIMIDINE-FUSED CYCLIC COMPOUND AND PREPARATION METHOD AND USE THEREOF | 劲方医药科技(上海)有限公司 | 2023-03-09 | — | — | WO | disclosed |
| US-20220227786-A1 | Spiro Bicyclic Inhibitors Of Menin-MLL Interaction | JANSSEN PHARMACEUTICA NV (BE) | 2022-07-21 | — | — | US | disclosed |
| CN-107873030-B | 5-HT2CReceptor agonists and compositions and methods of use | 艾尼纳制药公司 | 2021-03-19 | — | — | CN | disclosed |
| EP-3735299-A2 | FUSED RING COMPOUNDS | F. Hoffmann-La Roche AG (CH) | 2020-11-11 | — | — | EP | disclosed |
| CN-210583153-U | Solid preparation of medicine for treating impotence and premature ejaculation | 厦门赛诺邦格生物科技股份有限公司 | 2020-05-22 | — | — | CN | disclosed |
| CN-105837584-B | The imidazole radicals imidazoles of condensation as antiviral compound | 吉利德制药有限责任公司 | 2018-07-13 | — | — | CN | disclosed |
| CN-107011350-A | Antiviral compound | 吉利德科学公司 | 2017-08-04 | — | — | CN | disclosed |
| CN-104918943-B | Antiviral compounds | 吉利德科学公司 | 2017-04-05 | — | — | CN | disclosed |
| EP-1963262-A2 | N-HYDROXYAMIDE DERIVATIVES POSSESSING ANTIBACTERIAL ACTIVITY | Vicuron Pharmaceuticals, Inc. (US) | 2008-09-03 | — | — | EP | disclosed |
| WO-2007069020-A2 | N-HYDROXYAMIDE DERIVATIVES POSSESSING ANTIBACTERIAL ACTIVITY | VICURON PHARMACEUTICALS INC. (US) | 2007-06-21 | — | — | WO | disclosed |
| CN-1942438-A | Proline derivatives as pharmaceutical active ingredients in the treatment of tumors | SALAMA Z B (DE) | 2007-04-04 | — | — | CN | disclosed |
| CN-1744918-A | Polymeric reagents comprising a ketone or a related functional group | NEKTAR THERAPEUTICS AL CORP (US) | 2006-03-08 | — | — | CN | disclosed |
| EP-0932619-A1 | MACROCYCLIC PEPTIDES USEFUL IN THE TREATMENT OF THROMBIN RELATED DISORDERS | Ortho-McNeil Pharmaceutical, Inc. (US) | 1999-08-04 | — | — | EP | disclosed |
| US-5888971-A | ANTICOAGULANT | ORTHO PHARMACEUTICAL CORPORATION, INC. (US) | 1999-03-30 | — | — | US | disclosed |
| US-5801274-A | N- mercaptoacyl(amino acid or peptide)! compounds and S-lipophilic aliphatic carbonyl derivatives thereof as antihypertensives | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (FR) | 1998-09-01 | — | — | US | disclosed |
| WO-1997030080-A1 | MACROCYCLIC PEPTIDES USEFUL IN THE TREATMENT OF THROMBIN RELATED DISORDERS | ORTHO PHARMACEUTICAL CORPORATION (US) | 1997-08-21 | — | — | WO | disclosed |
| US-5591891-A | PEPTIDASE INHIBITORS | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) | 1997-01-07 | — | — | US | disclosed |
| WO-1994017036-A1 | S-LIPOPHILIC ALIPHATIC CARBONYL [N-MERCAPTOACYL-(AMINO ACID OR PEPTIDE)] COMPOUNDS AS ANTIHYPERTENSIVE AGENTS | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) | 1994-08-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12084462-B2 | Spiro bicyclic inhibitors of menin-MLL interaction | BMI1, MLLT1, MEN1 | ALDH1A1 2638/4885SMN1; SMN2 1839/4885RAB9A 3072/4885 |
| US-20220227786-A1 | Spiro Bicyclic Inhibitors Of Menin-MLL Interaction | BMI1, MLLT1, MEN1 | ALDH1A1 2638/4885SMN1; SMN2 1839/4885RAB9A 3072/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.